Skip to main content
. 2019 Feb 27;25(9):1569–1576. doi: 10.1093/ibd/izz030

FIGURE 1.

FIGURE 1.

Flow diagram of patient follow-up. *3 Three patients were kept on vedolizumab and had a response charted after 1 year and remained on therapy. One patient did not have a clinical assessment until after one year and did respond and remains on therapy.